Journal
JACC: Basic to Translational Science
Publication Date
3-1-2025
Volume
10
Issue
3
First Page
367
Last Page
380
Document Type
Open Access Publication
DOI
10.1016/j.jacbts.2024.12.010
Rights and Permissions
Panigrahy D, Kelly AG, Quinlivan KM, Wang W, Yang J, Hwang SH, Gillespie M, Howard IV, Bueno-Beti C, Asimaki A, Penna V, Lavine K, Edin ML, Zeldin DC, Hammock BD, Saffitz JE. Inhibition of Soluble Epoxide Hydrolase Reduces Inflammation and Myocardial Injury in Arrhythmogenic Cardiomyopathy. JACC Basic Transl Sci. 2025 Mar;10(3):367-380. doi: 10.1016/j.jacbts.2024.12.010. © 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Recommended Citation
Panigrahy, Dipak; Penna, Vinay; Lavine, Kory; and et al., "Inhibition of soluble epoxide hydrolase reduces inflammation and myocardial injury in arrhythmogenic cardiomyopathy." JACC: Basic to Translational Science. 10, 3. 367 - 380. (2025).
https://digitalcommons.wustl.edu/oa_4/5347
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
